Bioavailability of etravirine 200mg administered as a single 200-mg tablet versus two 100-mg tablets in HIV-negative, healthy volunteers

Trial Profile

Bioavailability of etravirine 200mg administered as a single 200-mg tablet versus two 100-mg tablets in HIV-negative, healthy volunteers

Completed
Phase of Trial: Phase I

Latest Information Update: 07 Aug 2013

At a glance

  • Drugs Etravirine (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 07 Aug 2013 Results published in the International Journal of Clinical Pharmacology and Therapeutics.
    • 03 Aug 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top